Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of placental-derived advanced biomaterial ...

Advanced biomaterials is a rapidly progressing field exploring the application of novel and conventional materials to restoring structure and function. It has recently been augmented by advances in 3D ...

Gain both academic and commercial perspectives on specific applications of biomaterials in personalized healthcare including orthopedics, wound care, and regenerative engineering. This ACS Webinar is ...

(Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of placental-derived advanced biomaterial products ...

Daniel Hale Williams Professor Guillermo Ameer, D.Sc., works to apply regenerative engineering and nanotechnology to organ and tissue regeneration and wound healing. His bioengineering efforts ...

Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from ...

FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial ...

At the end of its lifecycle, Series M biomaterial can be recycled or biodegraded naturally. Utilising waste and regenerative sources, TômTex minimises water, energy and land use. This ...

In 2019, the two companies joined forces to develop regenerative systems for the cultivation of cotton, working with rural smallholders in Mato Grosso. “The state of Mato Grosso is the second ...

(Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, today announced that Robert J.